DF II GP Sarl is 10% Owner at Cyteir Therapeutics, Inc. (CYT). They have made 1 open-market trade across 1 company since 2021, most recently 2021-06-22.
CIK 0001867855
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $5.0M since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CYT | 3,259,026 | $9.8M |
Shares reported on the most recent Form 4, priced at the 2021-06-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CYT | BUY | 2021-06-22 | 2021-06-24 | $18.00 | $5.0M | +5.9% | -13.0% | -12.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.